Global Sheep and Goat Pox Vaccines Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2016-2027
- Published Date: 2021-04-23
- Report ID: 106161
- Pages: 113
-
Format:
Summary
As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.
Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. Prudent Markets published a report for global Sheep and Goat Pox Vaccines market in this environment.
In terms of revenue, this research report indicated that the global Sheep and Goat Pox Vaccines market was valued at USD XXX million in 2020, and it is expected to reach a value of USD XXX million by 2027, at a CAGR of XX % over the forecast period 2021-2027. Correspondingly, the forecast analysis of Sheep and Goat Pox Vaccines industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.
The Agrovet aims at producing XX K Units Sheep and Goat Pox Vaccines in 2020, with XX % production to take place in global market, Biopharma accounts for a volume share of XX %.
Regional Segmentation (Value; Revenue, USD Million, 2026-2027) of Sheep and Goat Pox Vaccines Market by Prudent Markets Include
China
EU
USA
Japan
India
Southeast Asia
South America
Competitive Analysis; Who are the Major Players in Sheep and Goat Pox Vaccines Market
Agrovet
Biopharma
Dollvet
FGBI - Federal Centre for Animal Health
Hester Biosciences Limited
Indian Immunologicals Limited
Institut Pasteur d'Algerie
Intervac (PVT) Ltd.
JOVAC
Tiankang Biopharmacuetical
Vetal Company
Veterinary Research Institute
...
Major Type of Sheep and Goat Pox Vaccines Covered in Prudent Markets report:
Live Vaccines
Killed Vaccines
Application Segments Covered in Prudent Markets Market
Sheep
Goat
Application 3
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Sheep and Goat Pox Vaccines Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Live Vaccines -Product Introduction and Major Manufacturers
1.1.2 Killed Vaccines -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Global Sheep and Goat Pox Vaccines Market Assessment, by Segmentation
2.1 Type Breakdown Estimates & Forecast, Sales Volume (2026-2027)
2.2 Type Breakdown Estimates & Forecast, Sales Value (2026-2027)
2.3 Application Breakdown Estimates & Forecast, by Application (2026-2027)
3 Regional Market Analysis
3.1 China Sheep and Goat Pox Vaccines Market
3.1.1 Top Companies leading Sheep and Goat Pox Vaccines Development in China (2016-2021)
3.1.2 Sales Value of Major Company in China Market (2016-2021)
3.1.3 China Sheep and Goat Pox Vaccines Price (USD/Unit), by Type (2019-2020)
3.1.4 Sales in China Market, by Type (2026-2027)
3.2 EU Sheep and Goat Pox Vaccines Market
3.2.1 Top Companies leading Sheep and Goat Pox Vaccines Development in EU (2016-2021)
3.2.2 Sales Value of Major Company in EU Market (2016-2021)
3.2.3 EU Sheep and Goat Pox Vaccines Price (USD/Unit), by Type (2019-2020)
3.2.4 Sales in EU Market, by Type (2026-2027)
3.3 USA Sheep and Goat Pox Vaccines Market
3.3.1 Top Companies leading Sheep and Goat Pox Vaccines Development in USA (2016-2021)
3.3.2 Sales Value of Major Company in USA Market (2016-2021)
3.3.3 USA Sheep and Goat Pox Vaccines Price (USD/Unit), by Type (2019-2020)
3.3.4 Sales in USA Market, by Type (2026-2027)
3.4 Japan Sheep and Goat Pox Vaccines Market
3.4.1 Top Companies leading Sheep and Goat Pox Vaccines Development in Japan (2016-2021)
3.4.2 Sales Value of Major Company in Japan Market (2016-2021)
3.4.3 Japan Sheep and Goat Pox Vaccines Price (USD/Unit), by Type (2019-2020)
3.4.4 Sales in Japan Market, by Type (2026-2027)
3.5 India Sheep and Goat Pox Vaccines Market
3.5.1 Top Companies leading Sheep and Goat Pox Vaccines Development in India (2016-2021)
3.5.2 Sales Value of Major Company in India Market (2016-2021)
3.5.3 India Sheep and Goat Pox Vaccines Price (USD/Unit), by Type (2019-2020)
3.5.4 Sales in India Market, by Type (2026-2027)
3.6 Southeast Asia Sheep and Goat Pox Vaccines Market
3.6.1 Top Companies leading Sheep and Goat Pox Vaccines Development in Southeast Asia (2016-2021)
3.6.2 Sales Value of Major Company in Southeast Asia Market (2016-2021)
3.6.3 Southeast Asia Sheep and Goat Pox Vaccines Price (USD/Unit), by Type (2019-2020)
3.6.4 Sales in Southeast Asia Market, by Type (2026-2027)
3.7 South America Sheep and Goat Pox Vaccines Market
3.7.1 Top Companies leading Sheep and Goat Pox Vaccines Development in South America (2016-2021)
3.7.2 Sales Value of Major Company in South America Market (2016-2021)
3.7.3 South America Sheep and Goat Pox Vaccines Price (USD/Unit), by Type (2019-2020)
3.7.4 Sales in South America Market, by Type (2026-2027)
4 Value Chain (Impact of COVID-19)
4.1 Sheep and Goat Pox Vaccines Value Chain Analysis
4.1.1 Upstream
4.1.2 Downstream
4.2 COVID-19 Impact on Sheep and Goat Pox Vaccines Industry
4.2.1 Industrial Policy Issued Under the Epidemic Situation
4.3 Cost-Under the Epidemic Situation
4.3.1 Cost of Raw Material
4.4 Channel Analysis
4.4.1 Distribution Channel-Under the Epidemic Situation
4.4.2 Distributors
5 Regional Market Forecast (2021-2027)
5.1 Global Sheep and Goat Pox Vaccines Sales and Growth Rate (2021-2027)
5.2 Global Sheep and Goat Pox Vaccines Sales Value and Growth Rate (2021-2027)
6 Sheep and Goat Pox Vaccines Competitive Analysis
6.1 Agrovet
6.1.1 Agrovet Company Profiles
6.1.2 Agrovet Product Introduction
6.1.3 Agrovet Sheep and Goat Pox Vaccines Production, Revenue (2016-2021)
6.1.4 SWOT Analysis
6.2 Biopharma
6.2.1 Biopharma Company Profiles
6.2.2 Biopharma Product Introduction
6.2.3 Biopharma Sheep and Goat Pox Vaccines Production, Revenue (2016-2021)
6.2.4 SWOT Analysis
6.3 Dollvet
6.3.1 Dollvet Company Profiles
6.3.2 Dollvet Product Introduction
6.3.3 Dollvet Sheep and Goat Pox Vaccines Production, Revenue (2016-2021)
6.3.4 SWOT Analysis
6.4 FGBI - Federal Centre for Animal Health
6.4.1 FGBI - Federal Centre for Animal Health Company Profiles
6.4.2 FGBI - Federal Centre for Animal Health Product Introduction
6.4.3 FGBI - Federal Centre for Animal Health Sheep and Goat Pox Vaccines Production, Revenue (2016-2021)
6.4.4 SWOT Analysis
6.5 Hester Biosciences Limited
6.5.1 Hester Biosciences Limited Company Profiles
6.5.2 Hester Biosciences Limited Product Introduction
6.5.3 Hester Biosciences Limited Sheep and Goat Pox Vaccines Production, Revenue (2016-2021)
6.5.4 SWOT Analysis
6.6 Indian Immunologicals Limited
6.6.1 Indian Immunologicals Limited Company Profiles
6.6.2 Indian Immunologicals Limited Product Introduction
6.6.3 Indian Immunologicals Limited Sheep and Goat Pox Vaccines Production, Revenue (2016-2021)
6.6.4 SWOT Analysis
6.7 Institut Pasteur d'Algerie
6.7.1 Institut Pasteur d'Algerie Company Profiles
6.7.2 Institut Pasteur d'Algerie Product Introduction
6.7.3 Institut Pasteur d'Algerie Sheep and Goat Pox Vaccines Production, Revenue (2016-2021)
6.7.4 SWOT Analysis
6.8 Intervac (PVT) Ltd.
6.8.1 Intervac (PVT) Ltd. Company Profiles
6.8.2 Intervac (PVT) Ltd. Product Introduction
6.8.3 Intervac (PVT) Ltd. Sheep and Goat Pox Vaccines Production, Revenue (2016-2021)
6.8.4 SWOT Analysis
6.9 JOVAC
6.9.1 JOVAC Company Profiles
6.9.2 JOVAC Product Introduction
6.9.3 JOVAC Sheep and Goat Pox Vaccines Production, Revenue (2016-2021)
6.9.4 SWOT Analysis
6.10 Tiankang Biopharmacuetical
6.10.1 Tiankang Biopharmacuetical Company Profiles
6.10.2 Tiankang Biopharmacuetical Product Introduction
6.10.3 Tiankang Biopharmacuetical Sheep and Goat Pox Vaccines Production, Revenue (2016-2021)
6.10.4 SWOT Analysis
6.11 Vetal Company
6.12 Veterinary Research Institute
7 Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
